ETS Rearrangements, Neuroendocrine Modulators, and Androgen Resistance: What Can the Microenvironment Reveal in Prostate Cancer?

2019 ◽  
Vol 2 (4) ◽  
pp. 413-414
Author(s):  
Nirmish Singla
Keyword(s):  
Prostate Cancer ◽  
Androgen Resistance

scholarly journals MP68-18 ENZALUTAMIDE TREATMENT RESULTS IN ANTI-ANDROGEN RESISTANCE IN PATIENT-DERIVED BONE METASTATIC PROSTATE CANCER MODELS

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Christina Jamieson* ◽  
Michelle Muldong ◽  
Danielle Burner ◽  
Christina Wu ◽  
Theresa Mendoza ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Treatment Results ◽  
Cancer Models ◽  
Androgen Resistance

Abstract 3030: HSD3B1 mediated anti-androgen resistance in prostate cancer requires specific androgen precursors

2019 ◽  
Author(s):  
Cameron M. Armstrong ◽  
Chengfei Liu ◽  
Wei Lou ◽  
Alan P. Lombard ◽  
Christopher Evans ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Resistance

scholarly journals Androgen resistance in prostate cancer

2008 ◽  
Vol 98 (1) ◽  
pp. 1-1 ◽  
Author(s):  
J Waxman ◽  
S Ngan
Keyword(s):  
Prostate Cancer ◽  
Androgen Resistance

Low-Level TOP2A Amplification in Prostate Cancer Is Associated with HER2 Duplication, Androgen Resistance, and Decreased Survival

2007 ◽  
Vol 67 (6) ◽  
pp. 2893-2898 ◽  
Author(s):  
Amanda J. Murphy ◽  
Caroline A. Hughes ◽  
Ciara Barrett ◽  
Hilary Magee ◽  
Barbara Loftus ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Low Level ◽  
Top2a Amplification ◽  
Androgen Resistance

Abstract PR09: Macrophage promotion of anti-androgen resistance in prostate cancer bone disease

2022 ◽  
Author(s):  
Xue-Feng Li ◽  
Cigdem Selli ◽  
Asier Unciti-Broceta ◽  
Neil O. Carragher ◽  
Hai-Yan Hu ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Disease ◽  
Androgen Resistance

Abstract 3030: HSD3B1 mediated anti-androgen resistance in prostate cancer requires specific androgen precursors

2019 ◽  
Author(s):  
Cameron M. Armstrong ◽  
Chengfei Liu ◽  
Wei Lou ◽  
Alan P. Lombard ◽  
Christopher Evans ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Androgen Resistance

PRE-TREATMENT SERUM TESTOSTERONE LEVEL IS ASSOCIATED WITH ANDROGEN RESISTANCE IN PRIMARY LHRH-AGONIST THERAPY FOR PROSTATE CANCER

2009 ◽  
Vol 181 (4S) ◽  
pp. 98-98
Author(s):  
Jeremy M Blumberg ◽  
Pejvak Sassani ◽  
T Craig Cheetham ◽  
Fang Niu ◽  
Steven J. Jacobsen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Testosterone Level ◽  
Serum Testosterone ◽  
Serum Testosterone Level ◽  
Lhrh Agonist ◽  
Agonist Therapy ◽  
Androgen Resistance ◽  
Pre Treatment
Sign in / Sign up

Export Citation Format

Share Document